Want to find your lens? Five questions, no jargon — they tell you which of four reads fits how you already think.
There's no rate to imply here.
The data isn't there yet — here's what's missing:
Why not
- Caution: What is missingCardinal Health closed a run of specialty-care acquisitions in 2025 — GI Alliance for about $2.8B, plus Advanced Diabetes Supply and Integrated Oncology Network — and only its most recent annual year carries any of them. Because those businesses earn very differently from Cardinal's pharmaceutical distribution, they shift the operating-profit and invested-capital mix the read is built on more than the revenue line shows. A five-year base that reflects them is several filings out.
TickerMath is an educational tool, not investment advice — it computes one model from SEC filings and can be wrong. How we compute this →